Serum expression of selected miRNAs in patients with laryngeal squamous cell carcinoma (LSCC)

Diagnostic Pathology

Table 2 The results of eleven selected miRNAs analyzed by RT-qPCR

miRNA serum	Group	N	Mean+/−SD	p
miR-31	neoplastic	66	0,345 ± 0,090	< 0,001
miR-31	control	100	0,078 ± 0,036	< 0,001
miR-141	neoplastic	66	0,289 ± 0,079	< 0,001
miR-141	control	100	0,077 ± 0,082	< 0,001
miR-149a	neoplastic	66	0,168 ± 0,051	0,003
miR-149a	control	100	0,120 ± 0,028	0,003
miR-182	neoplastic	66	0,247 ± 0,091	< 0,001
miR-182	control	100	0,085 ± 0,076	< 0,001
miR-145	neoplastic	66	0,031 ± 0,017	< 0,001
miR-145	control	100	0,146 ± 0,124	< 0,001
miR-223	neoplastic	66	0,038 ± 0,032	< 0,001
miR-223	control	100	0,102 ± 0,035	< 0,001
LET-7a	neoplastic	66	0,298 ± 0,110	< 0,001
LET-7a	control	100	0,073 ± 0,034	< 0,001
miR-133a	neoplastic	66	0,058 ± 0,024	0,007
miR-133a	control	100	0,204 ± 0,156	0,007
miR-485-3p	neoplastic	66	0,394 ± 0,111	< 0,001
miR-485-3p	control	100	0,136 ± 0,078	< 0,001
miR-122	neoplastic	66	0,497 ± 0,202	< 0,001
miR-122	control	100	0,147 ± 0,058	< 0,001
miR-33	neoplastic	66	1013 ± 0,184	< 0,001
miR-33	control	100	0,136 ± 0,071	< 0,001

Significantly differentially expressed miRNAs in the serum of LSCC patients (n = 66) when compared to healthy controls (n = 100). Data represent the mean ± S.D

ISSN: 1746-1596